Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

The MYOT Gene and Your Muscle Scaffolding

At a Glance

Myotilinopathy (LGMD1A) is caused by mutations in the MYOT gene, which produces a poorly shaped myotilin protein. This mutated protein forms toxic clumps inside muscle cells and fails to support the muscle's structural scaffolding, resulting in progressive muscle weakness.

To understand Myotilinopathy (formerly LGMD1A), it helps to look inside your muscle fibers. Muscle cells are not just simple bags of fluid; they are highly organized engines made of microscopic “scaffolding” [1][2].

The MYOT Gene: The Blueprint

The MYOT gene provides the instructions (the “blueprint”) for your body to build a protein called myotilin [3][4]. In healthy muscle, myotilin is an essential structural component. Think of it as a specialized “connector” or “glue” that helps keep the muscle’s internal machinery properly aligned [1].

The Z-Disc: The Anchor Point

Inside every muscle fiber are thousands of tiny contracting units called sarcomeres. Each sarcomere is bordered by a structure called the Z-disc [5][6].

  • The Z-disc acts as an anchor for the muscle’s contracting parts [5].
  • It transmits force throughout the muscle so that when the sarcomeres shorten, the whole muscle pulls together [7][8].
  • Myotilin lives specifically at these Z-discs, stabilizing them and helping them withstand the mechanical stress of movement [9][10].

When the Blueprint Changes: Mutations

When the MYOT gene has a mutation, the myotilin protein is built with the wrong shape [4][11]. This “misspelling” in the genetic code leads to two major problems in the muscle fiber:

1. Protein Aggregation (The “Clump”)

This is often called a toxic gain-of-function [9]. Because the mutated myotilin is shaped incorrectly, it doesn’t fit into the Z-disc properly. Instead, it starts to stick to other proteins, forming abnormal clumps called protein aggregates [9][3].
Over time, these aggregates grow and become visible under a microscope as rimmed vacuoles or spheroid bodies [3][12]. These clumps “clog up” the muscle cell and interfere with its ability to clear out waste [3][13].

2. Myofibrillar Disorganization (The “Collapse”)

At the same time, because the myotilin isn’t at the Z-disc doing its job, the Z-disc becomes weak and unstable [9]. This is known as a loss-of-function [9].
Without the stabilizing “glue” of myotilin, the Z-discs begin to fray and disintegrate [3][4]. This is called myofibrillar disorganization [3][14]. As the internal scaffolding of the muscle fiber collapses, the fiber can no longer generate force, which you experience as muscle weakness [3][15].

A Rare “Multisystem” Protein

While myotilin is primarily found in skeletal muscle (like your biceps or calves), it is also present in heart muscle [3][16]. This is why the scaffolding breakdown can sometimes, though rarely, occur in the heart’s Z-discs [16][14].

By understanding that Myotilinopathy is a structural “scaffolding” problem, you and your medical team can better focus on strategies to protect your muscles and monitor your overall health [17][18].

Common questions in this guide

What does the MYOT gene do?
The MYOT gene provides your body with the instructions to build a protein called myotilin. In healthy muscles, myotilin acts as an essential connector that helps keep the internal machinery of the muscle aligned and stabilized during movement.
How does a MYOT mutation cause muscle weakness?
A mutation causes the myotilin protein to form with the wrong shape. This leads to two issues: the misshapen proteins clump together and clog the muscle cell, while the structural scaffolding of the muscle collapses, leading to weakness.
What are protein aggregates or rimmed vacuoles on my biopsy?
These are abnormal clumps of misfolded proteins that stick together inside the muscle fiber. Because they do not fit into the muscle structure properly, they build up over time and interfere with the cell's ability to function and clear out waste.
Can Myotilinopathy affect my heart?
Yes, although it is rare. While myotilin is mostly found in skeletal muscles like your arms or legs, it is also present in heart muscle. Your doctor may recommend regular cardiac screenings to monitor for any changes in your heart's structure.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you show me on my biopsy report where it mentions protein aggregates or 'rimmed vacuoles'?
  2. 2.Which specific mutation was found in my MYOT gene, and how does it affect the myotilin protein's shape?
  3. 3.Does the level of 'myofibrillar disorganization' seen in my biopsy correlate with my current level of muscle weakness?
  4. 4.Since myotilin is also present in heart muscle, should we be monitoring my cardiac Z-discs through regular screenings?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Molecular basis of F-actin regulation and sarcomere assembly via myotilin.

    Kostan J, Pavšič M, Puž V, et al.

    PLoS biology 2021; (19(4)):e3001148 doi:10.1371/journal.pbio.3001148.

    PMID: 33844684
  2. 2

    The Role of Z-disc Proteins in Myopathy and Cardiomyopathy.

    Wadmore K, Azad AJ, Gehmlich K

    International journal of molecular sciences 2021; (22(6)) doi:10.3390/ijms22063058.

    PMID: 33802723
  3. 3

    Myotilin gene duplication causing late-onset myotilinopathy.

    Spinazzi M, Savarese M, Letournel F, et al.

    European journal of neurology 2025; (32(1)):e70029 doi:10.1111/ene.70029.

    PMID: 39757377
  4. 4

    A novel in-frame deletion in MYOT causes an early adult onset distal myopathy.

    Guglielmi V, Pancheri E, Cannone E, et al.

    Clinical genetics 2023; (104(6)):705-710 doi:10.1111/cge.14413.

    PMID: 37553249
  5. 5

    The molecular basis for sarcomere organization in vertebrate skeletal muscle.

    Wang Z, Grange M, Wagner T, et al.

    Cell 2021; (184(8)):2135-2150.e13 doi:10.1016/j.cell.2021.02.047.

    PMID: 33765442
  6. 6

    Numb and Numblike regulate sarcomere assembly and maintenance.

    Wang B, Yang M, Li S

    The Journal of clinical investigation 2022; (132(3)).

    PMID: 35104799
  7. 7

    Three-dimensional structure of the basketweave Z-band in midshipman fish sonic muscle.

    Burgoyne T, Heumann JM, Morris EP, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2019; (116(31)):15534-15539 doi:10.1073/pnas.1902235116.

    PMID: 31320587
  8. 8

    Filamin protects myofibrils from contractile damage through changes in its mechanosensory region.

    Fisher LAB, Carriquí-Madroñal B, Mulder T, et al.

    PLoS genetics 2024; (20(6)):e1011101 doi:10.1371/journal.pgen.1011101.

    PMID: 38905299
  9. 9

    New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses.

    Maerkens A, Olivé M, Schreiner A, et al.

    Acta neuropathologica communications 2016; (4()):8 doi:10.1186/s40478-016-0280-0.

    PMID: 26842778
  10. 10

    Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.

    Pathak P, Blech-Hermoni Y, Subedi K, et al.

    Communications biology 2021; (4(1)):355 doi:10.1038/s42003-021-01864-1.

    PMID: 33742095
  11. 11

    Human Mutated MYOT and CRYAB Genes Cause a Myopathic Phenotype in Zebrafish.

    Cannone E, Guglielmi V, Marchetto G, et al.

    International journal of molecular sciences 2023; (24(14)) doi:10.3390/ijms241411483.

    PMID: 37511242
  12. 12

    Novel compound heterozygous mutations in the TTN gene: elongation and truncation variants causing limb-girdle muscular dystrophy type 2J in a Han Chinese family.

    Wang G, Lv X, Xu L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(5)):3427-3433 doi:10.1007/s10072-022-05979-z.

    PMID: 35239051
  13. 13

    Silencing MYOT Expression May Inhibit Autophagy in Human Skeletal Muscle Cells.

    Lin ZJ, Xu JM, Ji HY, et al.

    Disease markers 2023; (2023()):3350685 doi:10.1155/2023/3350685.

    PMID: 36776921
  14. 14

    Myofibrillar and distal myopathies.

    Palmio J, Udd B

    Revue neurologique 2016; (172(10)):587-593 doi:10.1016/j.neurol.2016.07.019.

    PMID: 27638134
  15. 15

    A case report: a heterozygous deletion (2791_2805 del) in exon 18 of the filamin C gene causing filamin C-related myofibrillar myopathies in a Chinese family.

    Miao J, Su FF, Liu XM, et al.

    BMC neurology 2018; (18(1)):79 doi:10.1186/s12883-018-1078-4.

    PMID: 29866061
  16. 16

    Multisystem Myotilinopathy, including Myopathy and Left Ventricular Noncompaction, due to the MYOT Variant c.179C>T.

    Finsterer J, Stöllberger C, Hasun M, et al.

    Case reports in cardiology 2020; (2020()):5128069 doi:10.1155/2020/5128069.

    PMID: 32509353
  17. 17

    Integrated proteomic and transcriptomic profiling identifies aberrant gene and protein expression in the sarcomere, mitochondrial complex I, and the extracellular matrix in Warmblood horses with myofibrillar myopathy.

    Williams ZJ, Velez-Irizarry D, Gardner K, Valberg SJ

    BMC genomics 2021; (22(1)):438 doi:10.1186/s12864-021-07758-0.

    PMID: 34112090
  18. 18

    The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy".

    Schänzer A, Schumann E, Zengeler D, et al.

    Journal of muscle research and cell motility 2021; (42(2)):381-397 doi:10.1007/s10974-021-09601-1.

    PMID: 33710525

This page provides educational information about the MYOT gene and Myotilinopathy for informational purposes only. It does not replace professional medical advice. Always consult your neurologist or genetic counselor regarding your specific diagnosis and care.

Get notified when new evidence is published on Autosomal dominant limb-girdle muscular dystrophy type 1A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.